胃泌素-17与胃蛋白酶原对原发性胃癌诊断效果及感染的影响

Diagnostic effect of secretin-17 and pepsinogen on primary gastric cancer and its effect on infection

  • 摘要: 目的 探讨胃泌素-17与胃蛋白酶原对原发性胃癌诊断效果及对感染的影响。方法 选取2013年1月-2016年12月于医院治疗的胃癌患者248例作为研究对象,根据患者胃癌分期分为早期胃癌组(T1~2)112例,晚期胃癌组(T3~4)136例,并选取同期130例健康体检者作为对照组,比较体检者和胃癌患者术前血清胃泌素-17含量、胃蛋白酶原的含量;比较术后感染和非感染患者的血清胃泌素-17含量、胃蛋白酶原的含量;确定胃泌素-17含量、胃蛋白酶原对原发性胃癌的特异性、敏感性、准确性;统计分析感染患者的病原菌情况。结果 术前早期胃癌组患者胃泌素-17,胃蛋白酶原Ⅰ,Ⅱ分别为(12.41±5.73)pmol/L,(60.34±8.14)ng/ml,(14.28±1.93)ng/ml均低于晚期胃癌组的(19.73±8.84)pmol/L,(87.53±12.42)ng/ml,(28.76±5.41)ng/ml(P<0.05)。胃泌素-17,胃蛋白酶原Ⅰ、胃蛋白酶原Ⅱ对胃癌的诊断最佳临界值分别为9.71 pmol/L,67.96 ng/ml,13.52 ng/ml,敏感性分别为80.83%,74.41%,88.78%,特异性分别为63.90%,55.24%,84.63%,准确性分别为59.07%,63.22%,59.58%。对照组体检者及未感染患者的胃泌素-17,胃蛋白酶原Ⅰ、胃蛋白酶原Ⅱ的含量均低于感染患者(P<0.05);胃泌素-17,胃蛋白酶原Ⅰ、胃蛋白酶原Ⅱ对胃癌术后感染的诊断最佳临界值分别为18.86 pmol/L,81.73 ng/ml,22.61 ng/ml,敏感性分别为84.22%,85.75%,82.11%,特异性分别为84.29%,87.74%,71.90%,准确性分别为69.77%,72.81%,67.44%。18例感染患者共培养分离病原菌21株,其中革兰阴性菌13株,革兰阳性菌7株,真菌1株。结论 胃泌素-17和胃蛋白酶原对原发性胃癌及胃癌术后感染均具有重要的诊断价值,应引起临床重视。

     

    Abstract: OBJECTIVE To investigate the effect of gastrin 17 and pepsinogen on primary gastric cancer and its effect on infection. METHODS A total of 248 patients with gastric cancer admitted to our hospital from Jan. 2013 to Dec. 2016 were selected as the subjects. Patients were divided into 112 cases of early gastric cancer group (T1-2) and 136 cases of advanced gastric cancer group (T3-4) according to the different stages of gastric cancer. A total of 130 healthy persons with physical examination were selected control group at the same time. The preoperative serum gastrin-17 content and pepsinogen content between physical examination and gastric cancer patients were compared, and the postoperative serum gastrin-17 content and pepsinogen content between infected patients and non-infected patients were compared. The specificity, sensitivity and accuracy of gastrin-17 content and pepsinogen to primary gastric cancer were determined. The pathogens in infected patients were statistically analyzed. RESULTS The levels of gastrin-17, pepsinogen Ⅰ and Ⅱ in early gastric cancer group were (12.41±5.73) pmol/L, (60.34±8.14) ng/ml, and (14.28±1.93) ng/ml, respectively, which were significantly lower than those in advanced gastric cancer group of (19.73±8.84) mol/L, (87.53±12.42) ng/ml, and (28.76±5.41) ng/ml , respectively (P<0.05). The best critical values of gastrin-17, pepsinogen Ⅰ and Ⅱ for the diagnosis of gastric cancer were 9.71 pmol/L,67.96 ng/ml,and 13.52 ng/ml, the sensitivities were 80.83%,74.41%,and 88.78%,the specificities were 63.9%,55.24%,and 84.63%, and the accuracies were 59.07%,63.22%,and 59.58%, respectively. The contents of gastrin-17, pepsinogen I and II in the control group and non-infected patients were significantly lower than those in the infected patients (P<0.05). The best critical values of gastrin-17, pepsinogen Ⅰ and Ⅱ for the diagnosis of postoperative infection of gastric cancer were 18.86 pmol/L,81.73ng/ml,and 22.6 1ng/ml, the sensitivities were 84.22%,85.75%, and 82.11%, the specificities were 84.29%,87.74%,and 71.90%, and the accuracies were 69.77%,72.81%,and 67.44%, respectively. Totally 21 strains of pathogenic bacteria were isolated from 18 cases of infected patients, including 13 strains of gram-negative bacteria, 7 strains of gram-positive bacteria and 1 strain of fungus. CONCLUSION Gastrin-17 and pepsinogen have important diagnostic values in primary gastric cancer and postoperative infection of gastric cancer, and we should pay attention to it in clinical practice.

     

/

返回文章
返回